Acid sphingomyelinase and its product ceramide has been implicated in the regulation of kidney function [8, 9, 31–33] in different pathological conditions such as obesity, hyperhomocysteinemia or diabetes. Here, SMPD1 is linked to obesity due to melanocortin 4 receptor deficiency.